As of 2025-09-18, the Relative Valuation of Guardant Health Inc (GH) is (87.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 57.19 USD, the upside of Guardant Health Inc based on Relative Valuation is -253.2%.
The range of the Relative Valuation is (78.31) - (83.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.6x - 39.0x | 31.4x |
| Forward P/E multiples | 19.8x - 25.2x | 21.4x |
| Fair Price | (78.31) - (83.55) | (87.60) |
| Upside | -236.9% - -246.1% | -253.2% |
| Date | P/E |
| 2025-09-17 | -17.24 |
| 2025-09-16 | -16.70 |
| 2025-09-15 | -16.51 |
| 2025-09-12 | -16.54 |
| 2025-09-11 | -17.12 |
| 2025-09-10 | -17.05 |
| 2025-09-09 | -17.91 |
| 2025-09-08 | -18.13 |
| 2025-09-05 | -18.12 |
| 2025-09-04 | -18.49 |
| 2025-09-03 | -19.61 |
| 2025-09-02 | -20.04 |
| 2025-08-29 | -20.32 |
| 2025-08-28 | -19.43 |
| 2025-08-27 | -19.14 |
| 2025-08-26 | -19.12 |
| 2025-08-25 | -18.65 |
| 2025-08-22 | -18.50 |
| 2025-08-21 | -18.47 |
| 2025-08-20 | -17.63 |
| 2025-08-19 | -17.65 |
| 2025-08-18 | -17.92 |
| 2025-08-15 | -17.74 |
| 2025-08-14 | -18.19 |
| 2025-08-13 | -17.65 |
| 2025-08-12 | -16.61 |
| 2025-08-11 | -16.51 |
| 2025-08-08 | -16.34 |
| 2025-08-07 | -15.19 |
| 2025-08-06 | -13.44 |
| 2025-08-05 | -13.91 |
| 2025-08-04 | -13.32 |
| 2025-08-01 | -12.48 |
| 2025-07-31 | -12.35 |
| 2025-07-30 | -13.62 |
| 2025-07-29 | -13.06 |
| 2025-07-28 | -13.34 |
| 2025-07-25 | -13.39 |
| 2025-07-24 | -13.71 |
| 2025-07-23 | -13.70 |
| 2025-07-22 | -13.94 |
| 2025-07-21 | -13.75 |
| 2025-07-18 | -14.00 |
| 2025-07-17 | -14.25 |
| 2025-07-16 | -14.41 |
| 2025-07-15 | -14.49 |
| 2025-07-14 | -15.00 |
| 2025-07-11 | -15.14 |
| 2025-07-10 | -15.46 |
| 2025-07-09 | -15.38 |